Lab Tests Required as part of the USCIC I693 Immigration Medical Exam

Immigration Testing

The U.S. Citizenship and Immigration Services (USCIS) requires certain medical examinations as part of the immigration process. The required lab tests for the Form I-693, Report of Medical Examination and Vaccination Record, may include:

  1. Syphilis (RPR or VDRL): This test checks for syphilis infection, a sexually transmitted disease.
  2. Gonorrhea: A test to check for gonorrhea, another sexually transmitted infection.
  3. Tuberculosis (TB) Testing: This typically involves a chest X-ray and/or a Tuberculin Skin Test (TST) or Interferon-Gamma Release Assay (IGRA) blood test. TB screening is a critical part of the immigration medical examination.
  4. HIV Antibody Test: To check for the presence of the human immunodeficiency virus (HIV), which causes AIDS.
  5. Other Tests: Depending on the specific circumstances and the doctor’s evaluation, additional tests or screenings may be required. These could include tests for communicable diseases or other medical conditions that may make an individual inadmissible to the United States.

It’s important to note that the exact requirements for lab tests can vary based on the individual’s medical history, country of origin, and specific circumstances. Applicants should undergo the immigration medical examination with a designated civil surgeon approved by USCIS, who will determine the necessary tests and examinations based on the current guidelines at the time of the examination.

Applicants should consult with the designated civil surgeon for their examination to ensure they fulfill all the required medical tests and vaccinations for immigration purposes, as these requirements may change over time. USCIS provides detailed guidance on the medical examination process, and it’s advisable to review the most up-to-date information on their website or consult with an immigration attorney for the latest requirements.

Maulik Shah

Hello. I am a Clinical Geneticist. My medical education is from the Medical College of Virginia (M.D. and Ph.D.). I worked at NIH in the lab that performed the very first human gene therapy trial and helped design some of the original recombinant adenovirus vectors for gene therapy. Since then, I have been a genetics research in both Academia and the Private sector and currently work as Lab Director for Applied InGENuity and QUASR Diagnostics

Leave a Reply